GoodRx Holdings, Inc. (GDRX)
3.53
+0.02
(+0.57%)
USD |
NASDAQ |
Aug 28, 16:00
3.545
+0.02
(+0.42%)
After-Hours: 20:00
GoodRx Holdings Cash from Operations (Quarterly) : 80.83M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.83M |
| March 31, 2026 | 11.84M |
| December 31, 2025 | 32.89M |
| September 30, 2025 | 76.02M |
| June 30, 2025 | 49.58M |
| March 31, 2025 | 9.413M |
| December 31, 2024 | 44.74M |
| September 30, 2024 | 86.86M |
| June 30, 2024 | 9.701M |
| March 31, 2024 | 42.59M |
| December 31, 2023 | 15.87M |
| September 30, 2023 | 60.27M |
| Date | Value |
|---|---|
| June 30, 2023 | 29.87M |
| March 31, 2023 | 32.29M |
| December 31, 2022 | 31.88M |
| September 30, 2022 | 33.73M |
| June 30, 2022 | 51.05M |
| March 31, 2022 | 30.12M |
| December 31, 2021 | 49.81M |
| September 30, 2021 | 48.56M |
| June 30, 2021 | 34.93M |
| March 31, 2021 | 45.48M |
| December 31, 2020 | 14.85M |
| September 30, 2020 | 32.67M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| LataMed AI Corp. | -0.055M |
| SCWorx Corp. | -0.0057M |
| Health Catalyst, Inc. | 0.275M |
| Claritev Corp. | 92.67M |
| iSpecimen, Inc. | -0.6896M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -14.41M |
| Cash from Financing (Quarterly) | -6.02M |
| Free Cash Flow | 131.70M |
| Free Cash Flow Per Share (Quarterly) | 0.1908 |
| Free Cash Flow to Equity (Quarterly) | 68.82M |
| Free Cash Flow to Firm (Quarterly) | 71.84M |
| Free Cash Flow Yield | 10.83% |